RedDrop Dx
RedDrop Dx is a Colorado-based medical device company that develops FDA-cleared, pain-free capillary blood collection devices (RedDrop ONE) for healthcare systems, telehealth platforms, clinical laboratories, and decentralized clinical trial operators.
- Company typePrivate
- Founded-
- HeadquartersFort Collins, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What RedDrop Dx does
RedDrop Dx, Inc. is a Fort Collins, Colorado-based medical device company that develops the RedDrop ONE single-use capillary blood collection lancet. The device is FDA 510(k) cleared (K234081) as a Class II blood lancet with integrated sharps injury prevention and is engineered for patient self-administration through one-finger activation with audible and visual feedback. Its 1mL collection tubes are designed specifically for high-throughput laboratory automation, targeting use cases that require consistent sample volumes and integration with existing lab workflows.
The company serves four primary customer segments: healthcare systems and hospitals, telehealth and digital health platforms, pediatric care settings, and clinical laboratories. Pain points addressed include patient discomfort with traditional venipuncture, poor compliance with blood draw requirements, and the lack of automation-ready capillary collection devices for decentralized and remote diagnostics.
RedDrop Dx generates revenue through hardware sales of its single-use device via a hybrid go-to-market model: direct enterprise sales to hospitals and labs, combined with channel partnerships through telehealth providers, digital health companies, and decentralized clinical trial operators. An e-commerce storefront sells demonstration units for evaluation purposes. Pricing is quote-based and not publicly disclosed. The company closed a $5 million oversubscribed Series Seed round in December 2025 (co-led by Innosphere Ventures and Stout Street Capital) and appointed its first Chief Growth Officer in February 2026, indicating a transition from regulatory clearance to commercial launch.
RedDrop Dx firmographics
Firmographics- Name
- RedDrop Dx
- Legal name
- RedDrop Dx, Inc.
- Website
- https://reddropdx.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- RedDrop Dx is a Colorado-based medical device company that develops FDA-cleared, pain-free capillary blood collection devices (RedDrop ONE) for healthcare systems, telehealth platforms, clinical laboratories, and decentralized clinical trial operators.
- Ownership category
- akta.pro rank
RedDrop Dx industry classification
Industry- Product category
- Medical Devices — Capillary Blood Collection
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics) (HLAHAAAN)
- akta.pro secondary industry
- Clinical Trial Sample Collection & Site Phlebotomy Services (HLAGACAJ)
Keywords
Where RedDrop Dx is headquartered
LocationHeadquarters
- HQ city
- Fort Collins
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
RedDrop Dx business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Device Sales: Sale of RedDrop ONE single-use capillary blood collection devices to healthcare systems, clinical laboratories, and telehealth providers. Devices are sold directly through enterprise sales and partner channels.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels3 records
RedDrop Dx product offering
Product offeringCore offering
RedDrop Dx develops and sells the RedDrop ONE, an FDA 510(k) cleared (K234081) single-use capillary blood collection lancet with integrated sharps injury prevention. The device enables virtually pain-free, one-finger-activated blood sampling with audible and visual feedback, paired with 1mL automation-ready collection tubes engineered for high-throughput clinical laboratory workflows. The offering targets healthcare systems, hospitals, clinical laboratories, telehealth providers, and decentralized clinical trial operators.
Product overview
RedDrop Dx offers a single unified product, the RedDrop™ One device, which is an FDA-cleared Class II single-use capillary blood collection lancet with integrated sharps injury prevention. The device is designed for remote and decentralized blood collection, enabling virtually pain-free sampling with one-finger activation, visual and audible indicators, and 1mL automation-ready collection tubes for high-throughput lab integration. The company is developing its platform for telehealth and diagnostics applications.
Differentiator
Problem solved
Functional benefit
Brands
- RedDrop ONE: FDA 510(k) cleared (K234081) single-use capillary blood collection device with integrated sharps injury prevention. Virtually pain-free, one-finger activation with audible and visual feedback. Designed for remote blood collection, digital health platforms, and telehealth diagnostics.
- RedDrop™ One - Demo Unit
Products and services
- RedDrop ONE RedDrop ONE is an FDA 510(k) cleared (K234081) Class II single-use capillary blood collection lancet with integrated sharps injury prevention. It provides virtually pain-free blood sampling through one-finger activation with audible and visual feedback, and pairs with 1mL collection tubes designed for high-throughput laboratory automation. The product is built for healthcare systems, clinical laboratories, telehealth providers, digital health platforms, and decentralized clinical trial operators seeking patient-friendly, automation-ready capillary blood collection.
- RedDrop ONE Demo Unit RedDrop ONE Demo Unit is a demonstration version of the FDA 510(k) cleared RedDrop ONE capillary blood collection device, made available for evaluation only and not for diagnostic use. It enables prospective healthcare organizations, clinical laboratories, telehealth platforms, and channel partners to evaluate device ergonomics, activation feedback, and 1mL tube compatibility before placing volume orders.
Companies that use RedDrop Dx
Customer profileSegments4 records
Ideal customer profiles4 records
RedDrop Dx technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
RedDrop Dx partnerships and signals
Strategic signalScale indicators3 records
Recent moves6 records
Expansion highlights5 records
RedDrop Dx competitors and assessment
Company assessmentDirect peers
- Tasso: Tasso develops FDA-cleared at-home capillary blood collection devices (OnDemand) for decentralized clinical trials and remote diagnostics, directly competing with RedDrop ONE in the same self-administered blood draw category.
- YourBio Health: YourBio Health offers the Touch device, a virtually pain-free capillary blood collection system for remote clinical and at-home diagnostics, and is the former employer of RedDrop's CGO — a directly comparable product and go-to-market model.
- Drawbridge Health: Drawbridge Health developed the OneDraw device for collecting capillary blood samples at home for clinical laboratory testing, directly competing with RedDrop in the decentralized sampling category.
- Babson Diagnostics: Babson Diagnostics is building a retail and at-home capillary blood testing ecosystem with its BetterWay technology, overlapping with RedDrop's target use cases of patient-friendly, decentralized diagnostics.
- OraSure Technologies: OraSure specializes in at-home sample collection devices (e.g., for infectious disease and genetic testing), addressing the same remote specimen-collection workflow that RedDrop targets.
- Trajan Group (Neoteryx): Trajan's Neoteryx business offers Mitra microsampling devices for remote dried-blood-spot collection, directly competing in the same at-home dried blood spot market segment RedDrop is targeting.
Broad incumbents
- Becton Dickinson (BD): BD is the dominant incumbent in lancets, capillary blood collection, and specimen management systems; BD's portfolio overlaps directly with RedDrop's lancet device but is part of a much broader medical device catalog.
- Roche Diagnostics: Roche offers capillary blood collection consumables integrated with its large diagnostic testing franchise, competing with RedDrop at the lab-workflow integration layer rather than as a specialized lancet.
- Abbott Diagnostics: Abbott manufactures capillary blood collection and point-of-care diagnostic devices across its broader diagnostics portfolio, providing overlapping but non-specialized competition to RedDrop's telehealth-focused positioning.
Emerging players
- Seventh Sense Biosystems: Seventh Sense Biosystems has historically pursued virtually painless capillary blood collection; it represents a more niche but technologically adjacent player in the painless sampling category.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
RedDrop Dx social profiles
Digital presenceRedDrop Dx compliance and trust
Trust signalCompliance1 record
RedDrop Dx financial estimates
Financial estimateRevenue estimate
Valuation estimate
RedDrop Dx leadership team
Management profileNumber of profiles
Profiles1 record
RedDrop Dx funding detail
Funding detailFunding overview
Funding rounds1 record
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
RedDrop Dx M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about RedDrop Dx
What does RedDrop Dx do?
RedDrop Dx develops and sells the RedDrop ONE, an FDA 510(k) cleared (K234081) single-use capillary blood collection lancet with integrated sharps injury prevention. The device enables virtually pain-free, one-finger-activated blood sampling with audible and visual feedback, paired with 1mL automation-ready collection tubes engineered for high-throughput clinical laboratory workflows. The offering targets healthcare systems, hospitals, clinical laboratories, telehealth providers, and decentralized clinical trial operators.
Is RedDrop Dx a public or private company?
RedDrop Dx is a private company. It is classified as venture growth investor backed and is currently operating.
When was RedDrop Dx founded?
RedDrop Dx was founded in -1. It employs 1 to 10 people.
Where is RedDrop Dx based?
RedDrop Dx is headquartered in Fort Collins, United States, in the North America region.
How does RedDrop Dx make money?
One revenue line is on record: device Sales.
Who are RedDrop Dx's main competitors?
Direct peers on record are Tasso, YourBio Health, Drawbridge Health, Babson Diagnostics, OraSure Technologies and Trajan Group (Neoteryx). Broad incumbents are Becton Dickinson (BD), Roche Diagnostics and Abbott Diagnostics. Seventh Sense Biosystems is listed as an emerging player.
Does RedDrop Dx have an API?
No public API is recorded for RedDrop Dx.
What industry is RedDrop Dx in?
RedDrop Dx's product category is Medical Devices — Capillary Blood Collection. Its primary akta.pro industry code is HLAHAAAN, Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics), with a secondary code of HLAGACAJ, Clinical Trial Sample Collection & Site Phlebotomy Services. Its NAICS code is 339112 and its SIC code is 3841.